SCHEMBL4580168

SCHEMBL4580168

COc1cc2ccoc2cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.55
CYP3A4 P08684 5/20 0.46
HSD17B10 Q99714 4/20 0.46
CASP1 P29466 2/20 0.46
CASP7 P55210 2/20 0.46
KDM4E B2RXH2 5/20 0.46
CYP2A6 P11509 3/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
NFKB1 P19838 1/20 0.46
MAOA P21397 1/20 0.46
ACHE P22303 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALDH1A1 P00352 4/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 3/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
AKR1B1 P15121 2/20 0.43
CA7 P43166 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30018039 0.92 MCL1 (0.47) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL12546789 0.86 CYP3A4 (0.43) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL5987112 0.84 CYP3A4 (0.45) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL27938872 0.84 MCL1 (0.58) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL29286601 0.84 MCL1 (0.60) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL20563591 0.84 CYP3A4 (0.42) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL19783419 0.84 MCL1 (0.41) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL21167302 0.81 CA12 (0.43) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL19753579 0.81 CYP3A4 (0.44) MCL1CYP3A4HSD17B10CASP1CASP7
SCHEMBL1301705 0.81 CYP3A4 (0.62) MCL1CYP3A4HSD17B10CASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114040959-A Photochromic and electrochromic diarylethene compounds with improved photostability and solubility 首诺加拿大公司 2022-02-11 CN disclosed
US-8598168-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2013-12-03 US disclosed
US-20080132503-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132503-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 MCL1 262/4885CYP3A4 4739/4885HSD17B10 464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.